Radiodermatitis

CTCAE V5.0

Moderate to brisk erythema; patchy moist desquamation, mostly confined to skin folds and creases; moderate edema

SIMPLIFIED GRADING

Moderate to brisk erythema, moderate edema

Ulcerations and moist erosions confined to skin folds

References

Peuvrel L, Cassecuel J, Bernier C, Quéreux G, Saint-Jean M, Le Moigne M, Frénard C, Khammari A, Dréno B; Supported by GESTIM Nantes group of cutaneous adverse events induced by cancer treatments. TOXICAN: a guide for grading dermatological adverse events of cancer treatments. Support Care Cancer. 2018;26:2871-7.

CTCAE V5.0

Moist desquamation in areas other than skin folds and creases; bleeding induced by minor trauma and abrasion

SIMPLIFIED GRADING

Widespread moist ulcerations and erosions, extending beyond skin folds

Bleeding on minor trauma

References

Peuvrel L, Cassecuel J, Bernier C, Quéreux G, Saint-Jean M, Le Moigne M, Frénard C, Khammari A, Dréno B; Supported by GESTIM Nantes group of cutaneous adverse events induced by cancer treatments. TOXICAN: a guide for grading dermatological adverse events of cancer treatments. Support Care Cancer. 2018;26:2871-7.

CTCAE V5.0

Life-threatening consequences; skin necrosis or ulceration of full thickness dermis; spontaneous bleeding from involved site; skin graft indicated

SIMPLIFIED GRADING

Necrosis, ulceration of full thickness dermis

Spontaneous bleeding

References

Peuvrel L, Cassecuel J, Bernier C, Quéreux G, Saint-Jean M, Le Moigne M, Frénard C, Khammari A, Dréno B; Supported by GESTIM Nantes group of cutaneous adverse events induced by cancer treatments. TOXICAN: a guide for grading dermatological adverse events of cancer treatments. Support Care Cancer. 2018;26:2871-7.